Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Siemens PETNET Solutions is a global leader in the manufacturing and distribution of positron emission tomography (PET) radiopharmaceuticals. As a subsidiary of Siemens Healthineers, it operates the largest network of cyclotron-equipped radiopharmacies in the world, with over 60 facilities across nine countries. The company provides healthcare providers with reliable access to a broad portfolio of PET tracers, including FDG and novel biomarkers for oncology, neurology, and cardiology. In addition to its own products, PETNET serves as a contract development and manufacturing organization (CDMO) for pharmaceutical partners, facilitating the commercialization of new diagnostic agents. Their extensive infrastructure and quality systems support the advancement of precision medicine and theranostics globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Siemens PETNET.